Anti-PD-1/PD-L1 therapy for renal cell carcinoma: challenges in the development of predictive biomarkers

被引：2
|
作者：
Kato, Renpei [1 ]
Obara, Wataru [1 ]
机构：
[1] Iwate Med Univ, Dept Urol, Morioka, Iwate, Japan
来源：
EXPERT REVIEW OF ANTICANCER THERAPY | 2022年 / 22卷 / 07期
关键词：
anti-PD-1/PD-L1; therapy; biomarker; renal cell carcinoma; PD-L1; expression; peripheral blood biomarkers; CIRCULATING TUMOR DNA; CHECKPOINT; EXPRESSION;
D O I：
10.1080/14737140.2022.2087631
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：667 / 669
页数：3
相关论文
共 50 条
  • [1] Predictive biomarkers of anti-PD-1/PD-L1 therapy in NSCLC
    Niu, Mengke
    Yi, Ming
    Li, Ning
    Luo, Suxia
    Wu, Kongming
    [J]. EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2021, 10 (01)
  • [2] Predictive biomarkers of anti-PD-1/PD-L1 therapy in NSCLC
    Mengke Niu
    Ming Yi
    Ning Li
    Suxia Luo
    Kongming Wu
    [J]. Experimental Hematology & Oncology, 10
  • [3] Radiologic Heterogeneity in Responses to Anti-PD-1/PD-L1 Therapy in Metastatic Renal Cell Carcinoma
    de Velasco, Guillermo
    Krajewski, Katherine M.
    Albiges, Laurence
    Awad, Mark M.
    Bellmunt, Joaquim
    Hodi, F. Stephen
    Choueiri, Toni K.
    [J]. CANCER IMMUNOLOGY RESEARCH, 2016, 4 (01) : 12 - 17
  • [4] Pneumonitis with anti-PD-1/PD-L1 therapy
    Naidoo, J.
    Cunningham, J.
    Woo, K. M.
    Hellmann, M. D.
    Postow, M. A.
    Drilon, A. E.
    Chaft, J. E.
    Lesokhin, A. M.
    Segal, N. H.
    Callahan, M. K.
    Rudin, C. M.
    Iyriboz, T.
    Wolchok, J. D.
    [J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 : S103 - S103
  • [5] Peripheral Blood Immune Cell-based Biomarkers in Anti-PD-1/PD-L1 Therapy
    Kim, Kyung Hwan
    Kim, Chang Gon
    Shin, Eui-Cheol
    [J]. IMMUNE NETWORK, 2020, 20 (01)
  • [6] Pneumonitis From Anti-PD-1/PD-L1 Therapy
    Balaji, Aanika
    Verde, Franco
    Suresh, Karthik
    Naidoo, Jarushka
    [J]. ONCOLOGY-NEW YORK, 2017, 31 (10): : 739 - +
  • [7] Predictive and Prognostic Role of PD-L1 in Urothelial Carcinoma Patients with Anti-PD-1/PD-L1 Therapy: A Systematic Review and Meta-Analysis
    Liu, Haoran
    Ye, Tao
    Yang, Xiaoqi
    Lv, Peng
    Wu, Xiaoliang
    Thou, Hui
    Lu, Hongyan
    Tang, Kun
    Ye, Zhangqun
    [J]. DISEASE MARKERS, 2020, 2020
  • [8] PREDICTIVE AND PROGNOSTIC ROLE OF PD-L1 IN UROTHELIAL CARCINOMA PATIENTS WITH ANTI-PD-1/PD-L1 THERAPY: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Tang, Kun
    Jiang, Kehua
    Zhou, Hui
    Liu, Haoran
    Ye, Zhangqun
    Xu, Hua
    [J]. JOURNAL OF UROLOGY, 2018, 199 (04): : E1040 - E1040
  • [9] Bim and soluble PD-L1 (sPD-L1) as predictive biomarkers of response to anti-PD-1 therapy in patients with melanoma and lung carcinoma.
    Dronca, Roxana Stefania
    Mansfield, Aaron Scott
    Liu, Xin
    Harrington, Susan
    Enninga, Elizabeth Ann
    Kottschade, Lisa A.
    Koo, Chi Wan
    McWilliams, Robert R.
    Block, Matthew Stephen
    Nevala, Wendy Kay
    Markovic, Svetomir
    Dong, Haidong
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [10] Research Progress of Anti-PD-1/PD-L1 Immunotherapy Related Mechanisms and Predictive Biomarkers in NSCLC
    Bie, Fenglong
    Tian, He
    Sun, Nan
    Zang, Ruochuan
    Zhang, Moyan
    Song, Peng
    Liu, Lei
    Peng, Yue
    Bai, Guangyu
    Zhou, Bolun
    Gao, Shugeng
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
12345